This group included 7% who improved by two NYHA classes during this time. Class III patients experienced the most significant improvements, compared with class II patients who had modest improvements. The NYHA classification is very helpful to monitor patients' functional status when the diagnosis is already established.

Understanding the Context

Moreover, it is not disease-specific at all. The same functional classes ... The MERIT-HF study included 3991 patients with CHF NYHA classes II IV and EF โ‰ค 40%. [46] Metoprolol significantly reduced the risk of death or heart transplantation by 32% compared with placebo.

Key Insights

The NYHA classification was originally designed as a clinical and not a research tool. [7] It was never meant to serve the purpose of establishing the diagnosis of HF. It was designed purely as a ... Two new analyses of the STEP-HFpEF trials show that semaglutide led to more weight loss in women than in men and that the GLP-1 therapy also improves NYHA class. The NYHA-FC is a subjective assessment of the severity of HF symptoms for patients who are grouped into Stages C and D.

Final Thoughts

In fact, recent relabeling of carvedilol extends its indication to all patients from NYHA class I (post-MI patients with LV dysfunction) through stable patients with NYHA class IV HF. Mean age 72, LVEF 53%, most with NYHA Class 2 and 3 HF. The primary endpoint was a composite of total worsening HF events (HHF or urgent visit) and CV death. Follow-up was 2.5 years.